|
1
|
Parkin DM: International variation.
Oncogene. 23:6329–6340. 2004. View Article : Google Scholar
|
|
2
|
Parkin DM, Whelan SL, Ferlay J, Raymond L
and Young J: Cancer Incidence in Five Continents. 8. IARC Press;
Lyon: 1997
|
|
3
|
McPherson K, Steel CM and Dixon JM: ABC of
breast diseases. Breast cancer-epidemiology, risk factors, and
genetics. BMJ. 321:624–628. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Indian Council of Medical Research.
National Cancer Registry programme: Consolidated report of the
population based cancer registries 1990–1996. Indian Council of
Medical Research; New Delhi: 2001
|
|
5
|
Mittra I, Badwe RA, Desai PB, Yeole BB and
Jussawalla DJ: Early detection of breast cancer in developing
countries. Lancet. 1:719–720. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rao DN and Ganesh B: Estimate of cancer
incidence in India in 1991. Indian J Cancer. 35:10–18.
1998.PubMed/NCBI
|
|
7
|
Magnusson C, Baron J, Persson I, Wolk A,
Bergström R, Trichopoulos D and Adami HO: Body size in different
periods of life and breast cancer risk in post-menopausal women.
Int J Cancer. 76:29–34. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hamajima N, Hirose K, Tajima K, et al:
Alcohol, tobacco and breast cancer-collaborative reanalysis of
individual data from 53 epidemiological studies, including 58,515
women with breast cancer and 95,067 women without the disease. Br J
Cancer. 87:1234–1245. 2002. View Article : Google Scholar
|
|
9
|
Gervais-Fagnou DD, Girouard C, Laperriere
N, Pintillie M and Goss PE: Breast cancer in women following
supradiaphragmatic irradiations for Hodgkin’s disease. Oncology.
57:224–231. 1999.
|
|
10
|
Calle EE, Rodriguez C, Walker-Thurmond K
and Thun MJ: Overweight, obesity, and mortality from cancer in a
prospectively studied cohort of U.S. adults. N Engl J Med.
348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bray F, McCarron P and Parkin DM: The
changing global patterns of female breast cancer incidence and
mortality. Breast Cancer Res. 6:229–239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Datta K and Biswas J: Influence of dietary
habits, physical activity and affluence factors on breast cancer in
East India: a case-control study. Asian Pac J Cancer Prev.
10:219–222. 2009.PubMed/NCBI
|
|
13
|
McMichael AJ and Giles GG: Cancer in
migrants to Australia: extending the descriptive epidemiological
data. Cancer Res. 48:751–756. 1988.PubMed/NCBI
|
|
14
|
Schulz M, Hoffmann K, Weikert C, Nöthlings
U, Schulze MB and Boeing H: Identification of a dietary pattern
characterized by high-fat food choices associated with increased
risk of breast cancer: the European Prospective Investigation into
Cancer and Nutrition (EPIC)-Potsdam Study. Br J Nutr. 100:942–946.
2008. View Article : Google Scholar
|
|
15
|
Collaborative Group on Hormonal Factors in
Breast Cancer. Breast cancer and breastfeeding: collaborative
reanalysis of individual data from 47 epidemiological studies in 30
countries, including 50302 women with breast cancer and 96973 women
without the disease. Lancet. 360:187–195. 2002. View Article : Google Scholar
|
|
16
|
Lord SJ, Bernstein L, Johnson KA, et al:
Breast cancer risk and hormone receptor status in older women by
parity, age of first birth, and breastfeeding: a case-control
study. Cancer Epidemiol Biomarkers Prev. 17:1723–1730. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Winer EP, Morrow M, Osborne CK and Harris
JR: Cancer of the breast. Section 2, Malignant Tumors of the
Breast. Cancer: Principles & Practice of Oncology. DeVita VT:
2. 6th edition. J.B. Lippincott; Philadelphia: pp. 1651–1659.
2000
|
|
18
|
Huo D, Adebamowo CA, Ogundiran TO, Akang
EE, Campbell O, Adenipekun A, Cummings S, Fackenthal J, Ademuyiwa
F, Ahsan H and Olopade OI: Parity and breastfeeding are protective
against breast cancer in Nigerian women. Br J Cancer. 98:992–996.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zeng Y, Xu MS, Tan SQ and Yin L: Analysis
of the risk factors of breast cancer. Nan Fang Y Yi Ke Da Xue Xue
Bao. 30:622–623. 2010.(In Chinese).
|
|
20
|
Beral V: Breast cancer and
hormone-replacement therapy in the Million Women Study. Lancet.
362:419–427. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moynahan ME, Pierce AJ and Jasin M: BRCA2
is required for homology-directed repair of chromosomal breaks. Mol
Cell. 7:263–272. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Davies AA, Masson JY, McIIwraith MJ,
Stasiak AZ, Stasiak A, Venkitaraman AR and West SC: Role of BRCA2
in control of the RAD51 recombination and DNA repair protein. Mol
Cell. 7:273–282. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pellegrini L, Yu DS, Lo T, Anand S, Lee M,
Blundell TL and Venkitaraman AR: Insights into DNA recombination
from the structure of a RAD51-BRCA2 complex. Nature. 420:287–293.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gayther SA, Mangion J, Russell P, Seal S,
Barfoot R, Ponder BA, Stratton MR and Easton D: Variation of risks
of breast and ovarian cancer associated with different germline
mutations of the BRCA2 gene. Nat Genet. 15:103–105. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thorlacius S, Olafsdottir G, Tryggvadottir
L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H,
Ogmundsdottir HM and Eyfjörd JE: A single BRCA2 mutation in male
and female breast-cancer families from Iceland with varied cancer
phenotypes. Nat Genet. 13:117–119. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Oddoux C, Struewing JP, Clayton CM, et al:
The carrier frequency of the BRCA2 6174delT mutation among
Ashkenazi Jewish individuals is approximately 1%. Nat Genet.
14:188–190. 1996.
|
|
27
|
Thorlacius S, Sigurdsson S, Bjarnadottir
H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H and
Eyfjord JE: Study of a single BRCA2 mutation with high carrier
frequency in a small population. Am J Hum Genet. 60:1079–1084.
1997.PubMed/NCBI
|
|
28
|
Phillips KA: Current perspectives on
BRCA1- and BRCA2-associated breast cancers. Inter Med J.
31:349–356. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peto J, Collins N, Barfoot R, Seal S,
Warren W, Rahman N, Easton DF, Evans C, Deacon J and Stratton MR:
Prevalence of BRCA1 and BRCA2 mutations in patients with
early-onset breast cancer. J Natl Cancer Inst. 91:943–949. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hopper JL, Southey MC, Dite GS, Jolley DJ,
Giles GG, McCredie MR, Easton DF and Venter DJ: Population-based
estimate of the average age-specific cumulative risk of breast
cancer for a defined set of protein-truncating mutations in BRCA1
and BRCA2. Cancer Epidemiol Biomarkers Prev. 8:741–747.
1999.PubMed/NCBI
|
|
31
|
Thorlacius S, Struewing JP, Hartge P,
Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S,
Tulinius H and Eyfjörd JE: Population-based study of risk of breast
cancer in carriers of BRCA2 mutation. Lancet. 352:1337–1339. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Keen JC and Davidson NE: The biology of
breast carcinoma. Cancer. 97:825–833. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bignell G, Micklem G, Stratton MR,
Ashworth A and Wooster R: The BRC repeats are conserved in
mammalian BRCA2 proteins. Hum Mol Genet. 6:53–58. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Benson FE, Stasiak A and West SC:
Purification and characterization of the human Rad51 protein, an
analogue of E. coli RecA. EMBO J. 13:5764–5771. 1994.PubMed/NCBI
|
|
35
|
Donovan JW, Milne GT and Weaver DT:
Homotypic and heterotypic protein associations control Rad51
function in double-strand break repair. Genes Dev. 8:2552–2562.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hays SL, Firmenich AA and Berg P: Complex
formation in yeast double-strand break repair: participation of
Rad51, Rad52, Rad55, and Rad57 proteins. Proc Natl Acad Sci USA.
92:6925–6929. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Loizidou MA, Michael T, Neuhausen SL,
Newbold RF, Marcou Y, Kakouri E, Daniel M, Papadopoulos P, Malas S,
Hadjisavvas A and Kyriacou K: DNA-repair genetic polymorphisms and
risk of breast cancer in Cyprus. Breast Cancer Res Treat.
115:623–627. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Debniak T, Scott RJ, Górski B, et al:
Common variants of DNA repair genes and malignant melanoma. Eur J
Cancer. 44:110–114. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fackenthal JD, Sveen L, Gao Q, et al:
Complete allelic analysis of BRCA1 and BRCA2 variants in young
Nigerian breast cancer patients. J Med Genet. 42:276–281. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Freedman ML, Penney KL, Stram DO, Le
Marchand L, Hirschhorn JN, Kolonel LN, Altshuler D, Henderson BE
and Haiman CA: Common variation in BRCA2 and breast cancer risk: a
haplotype-based analysis in the Multiethnic Cohort. Hum Mol Genet.
13:2431–2441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Saxena S, Szabo CI, Chopin S, Barjhoux L,
Sinilnikova O, Lenoir G, Goldgar DE and Bhatanager D: BRCA1 and
BRCA2 in Indian breast cancer patients. Hum Mutat. 20:473–474.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hedau S, Jain N, Husain SA, Mandal AK, Ray
G, Shahid M, Kant R, Gupta V, Shukla NK, Deo SSV and Das BC: Novel
germline mutations in breast cancer susceptibility genes BRCA1,
BRCA2 and p53 gene in breast cancer patients from India. Breast
Cancer Res and Treat. 88:177–186. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Weitzel JN, Lagos V, Blazer KR, Nelson R,
Ricker C, Herzog J, McGuire C and Neuhausen S: Prevalence of BRCA
mutations and founder effect in high-risk Hispanic families. Cancer
Epidemiol Biomarkers Prev. 14:1666–1671. 2005. View Article : Google Scholar : PubMed/NCBI
|
